Adma Biologics Inc.

Adma Biologics Inc. is a commercial biopharmaceutical company specializing in plasma-derived biologics used to treat patients with immune deficiencies and certain infectious disease risks. The company operates an integrated model that spans plasma collection, manufacturing, and commercialization, enabling control over key steps in the supply chain. Its primary business segments are ADMA BioManufacturing, which produces immunoglobulin and related plasma-based therapies, and Plasma Collection Centers, which secure source plasma for its products. Adma Biologics also sells plasma-derived intermediate fractions generated during its FDA-approved manufacturing processes and provides laboratory contracting services, with capabilities that include contract filling, labeling, and packing for select customers. The company serves healthcare providers and patients primarily in the United States, focusing on therapies for individuals with compromised or deficient immune systems who are at elevated risk for infections. Headquartered in Ramsey, New Jersey, Adma Biologics plays a specialized role in the biotechnology and healthcare sectors by supplying targeted plasma-derived therapeutic options.

Want to understand how we rate dividend safety? Read our full methodology